[HTML][HTML] COVID-19 and atrial fibrillation: Intercepting lines

M Donniacuo, A De Angelis, C Rafaniello… - Frontiers in …, 2023 - frontiersin.org
Almost 20% of COVID-19 patients have a history of atrial fibrillation (AF), but also a new-
onset AF represents a frequent complication in COVID-19. Clinical evidence demonstrates …

[HTML][HTML] The pharmacological treatment of chronic pain: from guidelines to daily clinical practice

G Marcianò, C Vocca, M Evangelista, C Palleria… - Pharmaceutics, 2023 - mdpi.com
In agreement with the International Association for the Study of Pain, chronic pain is an
unpleasant sensory and emotional experience associated with actual or potential tissue …

[HTML][HTML] Safety of short-term treatments with oral chloroquine and hydroxychloroquine in patients with and without COVID-19: a systematic review

S Marin, A Martin Val, M Bosch Peligero… - Pharmaceuticals, 2022 - mdpi.com
Chloroquine (CQ) and hydroxychloroquine (HCQ) have recently become the focus of global
attention as possible treatments for Coronavirus Disease 2019 (COVID-19). The current …

[HTML][HTML] Drug–drug interactions in vestibular diseases, clinical problems, and medico-legal implications

G Di Mizio, G Marcianò, C Palleria, L Muraca… - International Journal of …, 2021 - mdpi.com
Peripheral vestibular disease can be treated with several approaches (eg, maneuvers,
surgery, or medical approach). Comorbidity is common in elderly patients, so polytherapy is …

[HTML][HTML] Butein as a potential binder of human ACE2 receptor for interfering with SARS-CoV-2 entry: A computer-aided analysis

N Kapoor, SM Ghorai, PK Khuswaha… - Journal of Molecular …, 2022 - Springer
Natural products have been included in our dietary supplements and have been shown to
have numerous therapeutic properties. With the looming danger of many zoonotic agents …

[HTML][HTML] Overview of antiviral drug therapy for COVID-19: where do we stand?

R Esposito, D Mirra, L Sportiello, G Spaziano… - Biomedicines, 2022 - mdpi.com
The vaccine weapon has resulted in being essential in fighting the COVID-19 outbreak, but it
is not fully preventing infection due to an alarming spreading of several identified variants of …

The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based …

MM Alsmadi - Drug Metabolism and Personalized Therapy, 2023 - degruyter.com
Objectives Therapy failure caused by complex population-drug-drug (PDDI) interactions
including CYP3A4 can be predicted using mechanistic physiologically-based …

[HTML][HTML] Metalloproteases in Pain Generation and Persistence: A Possible Target?

G Marcianò, C Vocca, V Rania, R Citraro, G De Sarro… - Biomolecules, 2023 - mdpi.com
Matrix metalloproteinases (MMPs) are a large family of zinc-dependent proteolytic enzymes
associated with extracellular matrix protein turnover and tissue degradation. They participate …

[HTML][HTML] Current potential therapeutic approaches against SARS-CoV-2: a review

DK Yadav, DD Singh, I Han, Y Kumar, EH Choi - Biomedicines, 2021 - mdpi.com
The ongoing SARS-CoV-2 pandemic is a serious threat to public health worldwide and, to
date, no effective treatment is available. Thus, we herein review the pharmaceutical …

Ibuprofen in the Management of Viral Infections: The Lesson of COVID‐19 for Its Use in a Clinical Setting

G Marcianò, L Muraca, V Rania… - The Journal of Clinical …, 2023 - Wiley Online Library
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are commonly used for the management of
fever, pain, and inflammation. However, they have always been considered to have a …